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مقارنة أداء ثالثة معادالت خمتلفة تستخدم للحصول على تقدير سرعة الرتشيح 
الكبييب لدى املرضى العمانيني املصابني بداء السكري من النوع الثاين
�صليمة املقبالية و وعداهلل مل عابد
abstract: Objectives: Estimated glomerular filtration rate (eGFR) is an important component of a patient’s renal 
function profile. The Modification of Diet in Renal Disease (MDRD) equation and the Chronic Kidney Disease-
Epidemiology Collaboration (CKD-EPI) equation are both commonly used. The aim of this study was to compare 
the performance of the original MDRD186, revised MDRD175 and CKD-EPI equations in calculating eGFR in type 
2 diabetes mellitus (T2DM) patients in Oman. Methods: The study included 607 T2DM patients (275 males and 
332 females, mean age ± standard deviation 56 ± 12 years) who visited primary health centres in Muscat, Oman, 
during 2011 and whose renal function was assessed based on serum creatinine measurements. The eGFR was 
calculated using the three equations and the patients were classified based on chronic kidney disease (CKD) 
stages according to the National Kidney Foundation Kidney Disease Outcomes Quality Initiative guidelines. A 
performance comparison was undertaken using the weighted kappa test. Results: The median eGFR (mL/min/1.73 
m2) was 92.9 for MDRD186, 87.4 for MDRD175 and 93.7 for CKD-EPI. The prevalence of CKD stage 1 was 55.4%, 
44.7% and 57% while for stages 2 and 3 it was 43.2%, 54% and 41.8%, based on MDRD186, MDRD175 and CKD-EPI, 
respectively. The agreement between MDRD186 and CKD-EPI (к 0.868) was stronger than MDRD186 and MDRD175 
(к 0.753) and MDRD175 and CKD-EPI (к 0.730). Conclusion: The performances of MDRD186 and CKD-EPI were 
comparable. Considering that CKD-EPI-based eGFR is known to be close to isotopically measured GFR, the use of 
MDRD186 rather than MDRD175 may be recommended.
Keywords: Diet Modification; Chronic Renal Insufficiency; Epidemiology; Collaboration; Glomerular Filtration 
Rates; Type 2 Diabetes Mellitus; Oman.
اأهم و�صائل تقييم وظائف الكلى. وت�صتخدم �رشيريا معادلتان لتقدير هذا املعدل،  الهدف: يعترب تقدير معدل الرت�صيح الكبيبي )eGFR( من  امللخ�ص: 
املزمنة  الكلى  اأمرا�س  وبائيات  درا�صة  من  امل�صتخل�صة  املعادلة  والأخرى هي   )MDRD( الكلى  اأمرا�س  الغذائي يف  النمط  تعديل  معادلة  الأوىل هي 
املعادلة  اأداء  مع   )MDRD175( املعدلة  ون�صختها   )MDRD186( الأ�صلية  املعادلة  اأداء  مقارنة  هو  الدرا�صة  هذه  هدف  اإن   .)CKD-EPI( 
)CKD-EPI( عند املر�صى امل�صابني بداء ال�صكري يف عمان. الطريقة: �صملت الدرا�صة 607 مر�صى بال�صكري من النوع الثاين )332 اإناث و275 ذكور( 
اأعمارهم يف املتو�صط مع انحراف معياري يبلغ 12 ± 56 عاما م�صجلني يف املراكز ال�صحية الأولية يف م�صقط ب�صلطنة عمان خلل عام 2011م، ومت تقييم 
وظائف الكلى عندهم با�صتخدام تركيز الكرياتنني يف الدم. مت يف هذا البحث قيا�س معدل الرت�صيح الكبيبي با�صتخدام ثلث معادلت، ومت اأي�صا ت�صنيف 
اأن  النتائج: وجد  الكلي فيما يتعلق بنتائج مبادرات اجلودة.  اأمرا�س  الكلوي املزمن )CKD( عند هوؤلء املر�صى بح�صب معايري موؤ�ص�صة  حالة املر�س 
و�صيط  eGFR للمعادلت الثلث كان كالتايل بالن�صبة اإىل MDRD186 كان املعدل هو 92.9 مل دقيقة/1.73م2، و بالن�صبة اإىل MDRD175  كان 
املعدل هو 87.4 مل دقيقة/1.73م2، و بالن�صبة اإىل CKD-EPI كان املعدل 93.7 مل دقيقة/1.73م2. ووجد اأن معدل انت�صار مرحلة CKD الأوىل 
-EPIو MDRD175 ،MDRD186 كان %55.4، %44.7، و %57 ، يف حني كان للمرحلة الثانية والثالثة %43.2، %54 و %41.8 لكل من
 )MDRD175و MDRD186( كان اأقوى من التفاق بني )CKD-EPIو MDRD186( على التوايل. كما لوحظ اأن التفاق بني معادلتي CKD
و )MDRD175 وCKD-EPI(. اخلال�صة:  وجد يف هذه الدرا�صة اأن اأداء معادلتي MDRD186و EPI-CKD-EPI لتقديرGFR كان متقاربا 
جدا باملقارنة مع MDRD175و EPI .CKD، و للتقليل من معدل زيادة ت�صخي�س مراحل اأمرا�س الكلى املزمن CKD من امل�صتح�صن اإعادة النظر يف 
.MDRD175 مقارنة بCKD-EPI مع GFR وتقارب تقدير MDRD186 ا�صتخدام اأف�صلية
مفتاح الكلمات: تعديل النظام الغذائي؛ القصور الكلوي املزمن؛ الوبائيات؛ التعاون؛ معدل الرتشيح الكبييب؛ داء السكري من النوع الثاين؛ عمان. 
Comparison between Three Different  
Equations for the Estimation of Glomerular  
Filtration Rate in Omani Patients with Type 2 
Diabetes Mellitus
*Salima R. S. Al-Maqbali and Waad-Allah S. Mula-Abed
Comparison between Three Different Equations for the Estimation of Glomerular Filtration Rate  
in Omani Patients with Type 2 Diabetes Mellitus 
e198 | SQU Medical Journal, May 2014, Volume 14, Issue 2
Serum creatinine-based equations for calculating estimated glomerular filtration rate (eGFR) have an established role in the 
assessment of renal function; these equations have 
improved the detection and management of chronic 
kidney disease (CKD), particularly in the last decade. 
The eGFR relates better to kidney function than serum 
creatinine, which is less useful as a single criterion of 
kidney function.1,2 Several equations are available for 
the calculation of eGFR, with the most commonly 
used ones being the Cockroft-Gault formula (1976), 
the Modification of Diet in Renal Disease (MDRD) 
equation (1999) and the Chronic Kidney Disease-
Epidemiology Collaboration (CKD-EPI) equation 
(2009).3 
In order to calculate the eGFR, the Cockcroft-
Gault formula requires serum creatinine levels, age, 
gender and weight.4 It was originally based on the 
1886 Jaffe assay for creatinine measurement; hence, 
it should be interpreted cautiously when the new 
creatinine methods are used. The need for weight and 
body surface area correction has limited its routine 
implementation.5 The MDRD equation is based on 
serum creatinine measurements, age and gender. In 
addition, it takes into account ethnicity (for African 
Americans) with results adjusted to a body surface 
area of 1.73 m2.6–9 It is a popular equation that has been 
adopted for the classification of CKD in clinical practice 
by many international entities.1,7,8 Moreover, in 2006 
the Department of Health in England recommended 
all National Health Service laboratories to report 
eGFR based on MDRD with every serum creatinine 
result, with a similar approach being adopted in North 
America, Europe and Australia.5,10,11
In the original MDRD equation (MDRD186), a 
constant factor of 186 was used which was later 
revised and re-expressed by the same authors, Levey 
et al., to a constant factor of 175 (MDRD175). This 
was mainly due to the standardisation of creatinine 
assays against the isotope dilution-mass spectrometry 
reference method.7–9 The MDRD equation works 
reasonably well at eGFR ≤60 mL/min/1.73 m2, but 
underestimates GFR in subjects with a GFR ≥60 mL/
min/1.73 m2; thus, it has limited accuracy in this 
range.9 However, despite the improved standardisation 
of the creatinine assay, this limitation did not improve 
when using the new revised MDRD175 as compared 
to the gold-standard isotopically-based method.12 
The MDRD equation was revisited again by Levey 
et al. in 2009, who then derived a new equation, the 
CKD-EPI equation.12 This new equation appears to be 
more accurate in estimating the GFR in the range of 
low serum creatinine. It yields GFR values with better 
agreement for eGFR than MDRD when compared 
with radio-labelled methods.12,13 
The objective of this study was to compare 
the performance of the original MDRD186, revised 
MDRD175 and CKD-EPI equations for the calculation 
of eGFR, and their impact on classifying CKD stages 
in patients with type 2 diabetes mellitus (T2DM) 
attending primary health centres (PHCs) in Muscat, 
Oman.
Methods
This retrospective study was based on data from 
patients’ electronic records. All adult Omani 
T2DM patients registered in PHCs were considered 
candidates for inclusion in the study. The process 
involved multi-stage random selection of PHCs 
followed by the random selection of patients. The data 
were mainly for Omani adult patients aged ≥25 years 
who were diagnosed with T2DM between 1 January 
and 31 December 2011 (N = 607). The data included 
information such as age, gender, weight, height, 
duration of diabetes mellitus (DM), medications 
and serum creatinine levels. All duplicate tests were 
subsequently excluded. For those patients with more 
than one reported creatinine result, the most recent 
value was taken for analysis. Ethical approval for 
Advances in Knowledge 
- Several estimated glomerular filtration rate (eGFR) equations have been implemented and updated in clinical practice for improving 
diagnostic care in renal medicine. 
- This study examines the impact of different eGFR equations on the prevalence of chronic kidney disease (CKD) in diabetic patients 
attending primary health centres in Muscat, Oman. The most effective is the Modification of Diet in Renal Disease (MDRD) equation 
MDRD186 rather than MDRD175.
Application to Patient Care
- eGFR in renal profiles facilitates the early detection of renal impairment which will allow for early therapy in diabetic patients.
- eGFR equations yield comparable results in established CKD (stage 4 and 5); however, the results are usually variable in early CKD 
(stages 1, 2 and 3).
- This study provides data indicating that the most appropriate eGFR equation for the classification of CKD in diabetic patients is 
MDRD186 rather than MDRD175.
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the study was obtained from the Ministry of Health 
Research and Ethical Review & Approval Committee 
in December 2011.
For all patients, the laboratory measurement of 
serum creatinine was performed using a Synchron 
LX20 analyser (Beckman Coulter, Inc., Brea, California, 
USA). Serum creatinine was analysed by the kinetic 
alkaline picrate methodology which is traceable to 
the reference method based on isotope dilution-mass 
spectrometry (IDMS). For each patient, eGFR was 
calculated using MDRD186, MDRD175 and CKD-EPI 
[Table 1]. A factor of 1.0 was considered for ethnicity 
since no evidence was available for a correction factor 
related to the local population being studied, and there 
were no participants of African American ethnicity 
to allow the use of the factor 1.212.7–9 The patients 
were classified according to their eGFR values (in mL/
min/1.73 m2) into five CKD stages as per the National 
Kidney Foundation Kidney Disease Outcomes Quality 
Initiative guidelines: normal or CKD stage 1 - eGFR 
≥90; CKD stage 2 - eGFR 60–89; CKD stage 3 - eGFR 
30–59; CKD stage 4 - eGFR 15–29, and CKD stage 5 
- eGFR <15.10
The data for each PHC was entered separately 
using Microsoft Excel (Microsoft Corp., Redmond, 
Washington, USA). A final integrated Excel worksheet 
was exported to the Statistical Package for the Social 
Sciences (SPSS), Version 16 (IBM, Corp., Chicago, 
Illinois, USA) for final analysis. The demographic and 
clinical data were expressed as mean, median, standard 
deviation (SD) and range (minimum–maximum). For 
calculating the prevalence, a pre-determined cut-off 
value was used to identify the abnormal levels which 
had been taken from the international guidelines for 
each parameter. The number of abnormal results were 
divided by the population size in that group and then 
multiplied by 100 to yield the prevalence percentage. A 
comparison between the CKD stages calculated from 
the three eGFR equations was undertaken using the 
weighted kappa test for agreement: a kappa statistic 
(к) of 0.21–0.40 was considered fair agreement; 0.41–
0.60 a moderate agreement; 0.61–0.80 a substantial 
agreement, and 0.81–1.00 a near-perfect agreement.14
Results
The patients in this study (N = 607) included 275 males 
(45.3%) and 332 females (54.7%) aged 26–92 years with 
a mean age ± SD of 56 ± 12 years. They had a mean 
DM duration of 6.9 ± 0.2 years, a body mass index of 
30 ± 0.34, a glycated haemoglobin (HbA1C) level of 8 ± 
0.09 and an albumin-to-creatinine ratio of 8.8 ± 1.97. 
The median value for serum creatinine (µmol/L) was 
71 (range 33–339) and the eGFR (mL/min/1.73 m2) 
was 92.9 for MDRD186, 87.4 for MDRD175 and 93.7 for 
CKD-EPI [Table 2].
The distribution of CKD stages based on the three 
Table 1: Serum creatinine-based formulae for the 
calculation of estimated glomerular renal filtration rate 
MDRD formulae:
Original four-variable MDRD186 formula
7:
eGFR (mL/min/1.73 m2) = 186 (S.Cr in µmol/L x 0.011312)-
1.154 x (age)-0.203 x (0.742 if female) x (1.212 if African 
American/black)
*Revised four-variable MDRD175 formula
9:
eGFR (mL/min/1.73 m2) = 175 (S.Cr in µmol/L x 0.011312)-
1.154 x (age)-0.203 x (0.742 if female) x (1.212 if African 
American/black) 
CKD-EPI formulae12:
For female with Cr <62 µmol/L: 
eGFR (mL/min/1.73 m2) = 144 x (Cr/61.6)-0.329 x (0.993)age
For female with Cr >62 µmol/L:
eGFR (mL/min/1.73 m2) = 144 x (Cr/61.6)-1.209 x (0.993)age
For male with Cr <80 µmol/L:
eGFR (mL/min/1.73 m2) = 141 x (Cr/79.2)-0.411 x (0.993)age
For male with Cr >80 µmol/L:
eGFR (mL/min/1.73 m2) = 141 x (Cr/79.2)-1.209 x (0.993)age
MDRD = modification of diet in renal disease; eGFR = estimated 
glomerular filtration rate; S.Cr = serum creatinine; CKD-EPI = chronic 
kidney disease-epidemiology; Cr = creatinine.
*Recommended for creatinine assay standardised against isotope 
dilution-mass spectrometry.
Table 3: Prevalence of chronic kidney disease stages 
based on eGFR by MDRD and CKD-EPI formulae 









≥90 337 (55.4) 271 (44.7) 346 (57)
60–89 213 (35.1) 257 (42.3) 197 (32.5)
30–59 49 (8.1) 71 (11.7) 56 (9.3)
15–29 7 (1.2) 6 (1.0) 6 (1.0)
<15 1 (0.2) 2 (0.3) 2 (0.3)
eGFR = estimated glomerular filtration rate; MDRD = modification of 
diet in renal disease; CKD-EPI = chronic kidney disease-epidemiology.
Table 2: Different parameters in the diabetic population 
(N = 607) 
Variables Median Mean ± SD Range
Age in years 56.0 56.1 ± 12.5 26–92
Creatinine in µmol/L 71.0 75.7 ± 32.0 33–399
MDRD186 in mL/
min/1.73 m2
92.9 93.8 ± 27.6 13–188
MDRD175 in mL/
min/1.73 m2
87.4 88.3 ± 25.9 13–177
CKD-EPI in mL/
min/1.73 m2
93.7 89.3 ± 21.3 11–131
SD = standard deviation; MDRD = modification of diet in renal 
disease; CKD-EPI = chronic kidney disease-epidemiology.
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equations is shown in Table 3. Of the diabetic patients 
screened, 90.5%, 87% and 89.5% had an eGFR of ≥60 
mL/min/1.73 m2 (CKD stages 1 and 2) and 9.5%, 
13% and 10.5% had an eGFR of <60 mL/min/1.73 
m2 (CKD stages 3, 4 and 5) based on MDRD186, 
MDRD175 and CKD-EPI equations, respectively. The 
difference mainly involved CKD stages 1, 2 and 3. The 
distribution of patients was nearly the same between 
the three equations in CKD stages 4 and 5.
Based on the weighted kappa analysis (к 0.753), 
the agreement between MDRD186 and MDRD175 was 
found to be considerable. The MDRD175 overestimated 
66 (19.6%) and 22 (10.3%) patients as CKD stages 2 and 
3, respectively, who had been labelled as CKD stages 1 
and 2, respectively, using MDRD186. The MDRD186 and 
CKD-EPI showed near-perfect agreement (к 0.868). 
There were 13 (3.9%) and 8 (3.8%) patients with CKD 
stages 1 and 2 using MDRD186 who were reclassified 
into CKD stage 2 and 3 by CKD-EPI, respectively. On 
the other hand, 22 patients (10.3%) with CKD stage 
2 using MDRD186 were reclassified as CKD stage 1 
using CKD-EPI [Table 4]. The agreement between 
MDRD186 and CKD-EPI (к 0.868) was better than 
between MDRD175 and CKD-EPI (к 0.730). There was 
also a clear underestimation of GFR using MDRD175 
compared to CKD-EPI and MDRD186 for patients with 
eGFR ≥60 mL/min/1.73 m2. CKD-EPI reclassified 79 
(30.7%) patients from CKD stage 2 using MDRD175 
into CKD stage 1, and another 15 (21.1%) patients 
were reclassified as CKD stage 2 from stage 3 
Table 4: Comparison of the prevalence of chronic kidney disease stages based on eGFR by MDRD186 as compared 
with MDRD175 and CKD-EPI formulae in the study patients (N = 607)
eFGR in mL/
min/1.73 m2
MDRD186  n (%)
≥90 60–89 30–59 15–29 <15 Total к
MDRD175 ≥90 271 (80) - - - - 271
0.753
60–89 66 (20) 191 (87) - - - 257
30–59 - 22 (10.3) 49 (100) - - 71
15–29 - - - 6 (86) - 6
<15 - - - 1 (14) 1 (100) 2
Totals 337 213 49 7 1 607
CKD-EPI ≥90 324 (96) 22 (10.3) - - - 346
0.868
60–89 13 (4) 183 (85.9) 1 (2) - - 197
30–59 - 8 (3.8) 48 (98) - - 56
15–29 - - - 6 (86) - 6
<15 - - - 1 (14) 1 (100) 2
Totals 337 213 49 7 1 607
eGFR = estimated glomerular filtration rate; MDRD = modification of diet in renal disease; к = kappa statistic; CKD-EPI = chronic kidney disease-
epidemiology.
Table 5: Comparison of the prevalence of chronic kidney disease stages based on eGFR by MDRD175 as compared 
with MDRD186 and CKD-EPI formulae in the study patients (N = 607)
eFGR in mL/
min/1.73 m2
MDRD175  n (%)
≥90 60–89 30–59 15–29 <15 Total к
CKD-EPI ≥90 267 (98.5) 79 (30.7) - - - 346
0.753
60–89 4 (1.5) 178 (69.3) 15 (21.1) - - 197
30–59 - - 56 (78.8) - - 56
15–29 - - - 6 (100) - 6
<15 - - - 2 (100) 2
Totals 271 257 71 6 2 607




60–89 - 191 (74.3) 22 (31) - - 213
30–59 - - 49 (69) - - 49
15–29 - - - 6 (100) 1 (50) 7
<15 - - - - 1 (50) 2
Totals 271 257 71 6 2 607
eGFR = estimated glomerular filtration rate; MDRD = modification of diet in renal disease; к = kappa statistic; CKD-EPI = chronic kidney disease-
epidemiology.
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[Table 5]. Similarly, the MDRD186 equation reclassified 
66 (25.7%) and 22 (31.0%) patients as CKD stages 1 
and 2 who had been in stages 2 and 3, respectively, 
according to the MDRD175 equation.
A comparison of the data by age and gender 
between the three equations is shown in Table 6. 
The misclassification mostly involved CKD stages 
1, 2 and 3. Apparently, the misclassification between 
MDRD186 and MDRD175 included an underestimation 
of GFR by MDRD175 within all age groups, but 
particularly in those above 45 years of age. CKD-EPI 
overestimated GFR among those below 65 years of age 
and underestimated it in those over 65 as compared to 
MDRD186. Similarly, CKD-EPI reclassified CKD stage 
2 into stage 1 within all age groups as compared to 
MDRD175. The misclassification of CKD stages using 
MDRD186 and MDRD175 involved more males than 
females among those above 45 years of age. However, 
the misclassification by CKD-EPI from MDRD175 
apparently involved more females in the older age 
groups.  
Discussion
During the last decade, there has been increasing 
interest in the use of creatinine-based eGFR 
equations, with MDRD being considered the most 
valid formula.6,15 In its original format, the MDRD186 
was recommended to be modified to the revised 
MDRD175 for creatinine assays standardised to the 
IDMS reference method.7–9 In the current study, the 
median eGFR (mL/min/1.73 m2) was found to be 
92.9 for MDRD186, 87.4 for MDRD175 and 93.7 for 
CKD-EPI, with the values being almost comparable 
for MDRD186 and CKD-EPI. Only a few studies in 
the literature have compared the performance of 
MDRD186 to various other GFR equations; most of 
them compared MDRD175 with CKD-EPI. Chudleigh 
et al. compared the performance of MDRD186 and 
MDRD175 in their patient series based on the isotope 
gold-standard method.17 The study reported a GFR of 
114.9 ± 22.4 mL/min/1.73 m2 for the isotope method, 
an eGFR of 94.7 ± 22.0 mL/min/1.73 m2 for MDRD175 
and 89.9 ± 19.0 mL/min/1.73 m2 for MDRD186 (a CKD-
EPI equation was not available at that time). Based on 
these results, Chudleigh et al. concluded that MDRD175 
is superior to MDRD186 as its eGFR values were nearer 
to the isotope method than MDRD186.
17 These data 
were surprising and questionable, and the numerical 
results for the two MDRD equations in their study 
could not be verified mathematically. Following the 
implementation of CKD-EPI, several studies showed 
an improved agreement of eGFR using CKD-EPI 
compared to using MDRD175 based on isotope gold-
standard methods.12,13,18 However, these studies did 
not consider or include MDRD186 in their comparison 
with CKD-EPI. Nevertheless, a comparative study 
involving European diabetic patients concluded a 
significant correlation between MDRD186 (coefficient 
of determination [R2] 0.818) and CKD-EPI (R2 0.814) 
and the isotope gold-standard method.28
The difference in the prevalence of CKD using 
Table 6: Misclassification in CKD stages according to gender comparing different estimated glomerular filtration 
formulae in the study patients (N = 607)
Misclassifications of 
CKD stages
Age group in years MDRD186 and MDRD175 MDRD186 and CKD-EPI MDRD175 and CKD-EPI
Male Female Male Female Male Female
Stage 1→2 ≤35 4 - - - - -
36–45 4 5 - - - -
46–55 10 13 - - - -
56–65 5 5 - - - -
>65 3 - 6 - 1 1
Stage 2→3 46–55 2 - - - - -
56–65 4 3 - - - -
>65 5 8 3 5 - 1
Stage 2→1 ≤35 - - 1 - 5 -
36–45 - - 1 6 5 11
46–55 - - 4 5 14 18
56–65 - - - 5 9 13
>65 - - 1 - - 2
Stage 3→2 46–55 - - - - 2 -
56–65 - - - - 4 -
>65 - - - - 2 3
CKD = chronic kidney disease; MDRD = modification of diet in renal disease; CKD-EPI = chronic kidney disease-epidemiology.
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the three equations can mostly be attributed to 
the redistribution in the prevalence of CKD stages 
1, 2 and 3 as seen in the agreement analysis. The 
agreement between MDRD186 and CKD-EPI is more 
efficient (к 0.868) than the one between MDRD186 
and MDRD175 (к 0.753) or MDRD175 and CKD-EPI (к 
0.730). A recent meta-analysis comparing the use of 
the CKD-EPI equation and the MDRD equation found 
that, when using the revised MDRD equation, 24.4% 
of participants were reclassified to a higher eGFR 
category by the CKD-EPI equation and the prevalence 
of CKD stages 3 to 5 (eGFR <60 mL/min/1.73 m2) was 
reduced from 8.7% to 6.3%. The reclassification mainly 
involved CKD stage 3A to CKD stage 2.25
The distribution of gender and age within the 
misclassified cases was divided into two main groups: 
underestimated GFR and a subsequent reclassification 
of CKD stage, and overestimated GFR with a 
subsequent reclassification of CKD to a higher stage 
[Table 6]. When comparing MDRD175 with MDRD186, it 
was found that MDRD175 clearly underestimated GFR 
in all age groups and predominantly affected males. In 
contrast, when comparing CKD-EPI and MDRD186, 
the CKD-EPI predominantly underestimated GFR in 
those aged ≥65 years. The overestimation was much 
more pronounced when comparing CKD-EPI and 
MDRD175. In a large cohort study in the UK, Carter 
et al. reported a median eGFR determined by CKD-
EPI that was significantly higher than the median GFR 
determined by MDRD175 (82 versus 76 mL/min/1.73 
m2,19 P <0.0001 with an overall mean bias of 5.0%) 
and a lower eGFR in those aged ≥70 years using 
CKD-EPI. However, Kilbride et al. reported that the 
CKD-EPI equation appears less biased and reasonably 
accurate in estimating GFR in both younger and older 
populations.20 Earley et al. recently pointed out that 
neither MDRD nor CKD-EPI may be optimal for all ages 
and populations despite the potential promise of the 
CKD-EPI equation.21 Moreover, the CKD-EPI equation 
performed as inadequately as the MDRD equation in 
T2DM individuals.26,28 Patients’ characteristics seem 
to account for the previously reported differences in 
the performance of CKD-EPI and MDRD equations.27 
With the good agreement between MDRD186 and 
CKD-EPI, which is better than the agreement between 
MDRD175 and CKD-EPI, it is worth considering the 
use of MDRD186 whenever MDRD equations are 
implemented in practice, including in primary care— 
particularly bearing in mind the better agreement of 
CKD-EPI with radiolabelled methods. In addition, the 
CKD-EPI equation requires a complicated technical 
procedure in order to be incorporated into electronic 
healthcare systems.
The current cross-sectional study has some 
limitations. The study did not include a reference 
method for GFR measurements. However, comparison 
data were based on the status of MDRD and CKD-EPI 
equations in relation to the reference GFR methods 
in the cited publications. Also, the study was based 
mainly on single creatinine readings that might have 
affected the prevalence of CKD in the current diabetic 
population. Additionally, the population data were 
from PHCs; hence, many patients with CKD stages 
4 and 5 might not have been included as these cases 
are usually referred to tertiary care institutions. Also, 
the population was mainly Arab-Asian, and since 
Arab ethnicity was not referred to in the MDRD or 
CKD-EPI equation, the factor in the equation was 
assumed to be 1.0. Further studies may be needed to 
validate these equations in the Arab-Asian population, 
taking into consideration that validated Japanese and 
Chinese MDRD equations have been reported in the 
literature.22,23 For the Middle Eastern community, 
serum creatinine, age and gender have been utilised for 
estimating GFR using the aforementioned equations. 
No correction factor for ethnicity is considered 
which has led to the widespread acceptance of these 
equations by pathologists and clinicians.7,15,24 
Conclusion
The performance of MDRD186 and CKD-EPI in 
the calculation of GFR was, to a great extent, in 
agreement. Thus, calculated eGFR results using both 
equations were comparable. The revised MDRD175 
was found to underestimate GFR and thus increase 
the prevalence of CKD, particularly in stages 2 and 3, 
when compared with MDRD186 and CKD-EPI. Taking 
into consideration that CKD-EPI-based eGFR has 
been reported to be near to isotopically measured 
GFR, the use of MDRD186 may be recommended over 
MDRD175. Also, before making any decision to change 
from MDRD175 to CKD-EPI, the use of MDRD186 
should be considered.
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